ACTI — Active Biotech AB publ Income Statement
0.000.00%
Last trade - 00:00
- SEK224.35m
- SEK192.68m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 8.43 | 6.72 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 40.7 | 39 | 49.8 | 57.9 | 46.5 |
Operating Profit | -32.3 | -32.3 | -49.8 | -57.9 | -46.5 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -34.1 | -32.2 | -49.8 | -58.4 | -45.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | -34.1 | -32.2 | -49.8 | -58.4 | -45.8 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -34.1 | -32.2 | -49.8 | -58.4 | -45.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -34.1 | -32.2 | -49.8 | -58.4 | -45.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.169 | -0.161 | -0.203 | -0.224 | -0.169 |
Dividends per Share |